Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline vs Ertapenem in Diabetic Foot Infections
NCT00366249Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2007
- Primary completion
- Mar 2009
- Modality
- Orthosteric Ligands
- Countries
- 39
01
Overview
A Phase 3 trial of tigecycline in diabetic foot infection (DFI), sponsored by Pfizer. Started Jan 2007; status: completed.
02
Drugs
tigecycline
03
Conditions
diabetic foot infection (DFI)
Beyond the preview
Go deeper on NCT00366249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00366249.